Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Wilding

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Current Opinion in Pharmacology|January 5, 2002
Leptin and the control of obesityJ P Wilding
Biochemical Society Transactions|May 1, 1996
Metabolic actions of neuropeptide Y and their relevance to obesityJ P Wilding
Bailliere'S Best Practice & Research. Clinical Endocrinology & Metabolism|April 13, 2000
Obesity and diabetesK S Leong, J P Wilding
Frontiers of Hormone Research|April 18, 2000
Hypothalamic neuropeptide Y and its neuroendocrine regulation by leptinP S Widdowson, J P Wilding
Diabetes, Obesity & Metabolism|June 20, 2001
Insulin-sensitizing action of rosiglitazone is enhanced by preventing hyperphagiaL C Pickavance, R E Buckingham, J P Wilding
Diabetic Medicine : a Journal of the British Diabetic Association|July 27, 2010
Nurse-led clinics for strict hypertension control are effective long term: a 7 year follow-up studyA Woodward, M Wallymahmed, J P Wilding, et al.
Clinical Science (London, England : 1979)|May 16, 2001
Diet-induced endothelial dysfunction in the rat is independent of the degree of increase in total body weightE K Naderali, L C Pickavance, J P Wilding, et al.
The Journal of Endocrinology|March 1, 1997
Additive effects of lactation and food restriction to increase hypothalamic neuropeptide Y mRNA in ratsJ P Wilding, M O Ajala, P D Lambert, et al.
Clinical Endocrinology|June 26, 2001
The influence of growth hormone replacement on heart rate variability in adults with growth hormone deficiencyK S Leong, P Mann, M Wallymahmed, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|April 11, 2012
Effects of chronic treatment with metformin on dipeptidyl peptidase-4 activity, glucagon-like peptide 1 and ghrelin in obese patients with Type 2 diabetes mellitusS K Thondam, A Cross, D J Cuthbertson, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Current Opinion in Pharmacology|January 5, 2002
Leptin and the control of obesityJ P Wilding
Biochemical Society Transactions|May 1, 1996
Metabolic actions of neuropeptide Y and their relevance to obesityJ P Wilding
Bailliere'S Best Practice & Research. Clinical Endocrinology & Metabolism|April 13, 2000
Obesity and diabetesK S Leong, J P Wilding
Frontiers of Hormone Research|April 18, 2000
Hypothalamic neuropeptide Y and its neuroendocrine regulation by leptinP S Widdowson, J P Wilding
Diabetes, Obesity & Metabolism|June 20, 2001
Insulin-sensitizing action of rosiglitazone is enhanced by preventing hyperphagiaL C Pickavance, R E Buckingham, J P Wilding
Diabetic Medicine : a Journal of the British Diabetic Association|July 27, 2010
Nurse-led clinics for strict hypertension control are effective long term: a 7 year follow-up studyA Woodward, M Wallymahmed, J P Wilding, et al.
Clinical Science (London, England : 1979)|May 16, 2001
Diet-induced endothelial dysfunction in the rat is independent of the degree of increase in total body weightE K Naderali, L C Pickavance, J P Wilding, et al.
The Journal of Endocrinology|March 1, 1997
Additive effects of lactation and food restriction to increase hypothalamic neuropeptide Y mRNA in ratsJ P Wilding, M O Ajala, P D Lambert, et al.
Clinical Endocrinology|June 26, 2001
The influence of growth hormone replacement on heart rate variability in adults with growth hormone deficiencyK S Leong, P Mann, M Wallymahmed, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|April 11, 2012
Effects of chronic treatment with metformin on dipeptidyl peptidase-4 activity, glucagon-like peptide 1 and ghrelin in obese patients with Type 2 diabetes mellitusS K Thondam, A Cross, D J Cuthbertson, et al.
Pageof 4